Sign in to view content

Prophylaxis Intravitreal Aflibercept Against Conversion to Neovascular AMD in High-Risk Eyes (PRO-CON): 24-Month Results

Jeffrey S. Heier, MD

Video
Published 2019

Jeffrey S. Heier, MD

AMD Non-neovascular Symposium

Related

BiWeekly Anti-VEGF Dosing for Chronic Refractory Neovascular Age-Related Macular Degeneration Unresponsive to Standard Monthly Dosing
Eric W Schneider, MD
Annual Meeting Talks
2019
Therapeutic Horizons for Dry AMD
Robert L. Avery, MD
Updates from the Field
2019
Episode 113: Journal Club, Macular Ischemia in RISE/RIDE, Wet Conversion in AMD, Micropulse for CSR
Jayanth Sridhar, MD
Member Podcasts
2018

Category: AMD-Non-Neovascular

See more